Rockwell Medical, Inc. provided earnings guidance for the year 2025. For the year, the company projects net sales to grow in the mid-to-high single digits in 2025 and beyond.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.755 USD | -0.28% | -3.04% | -7.14% |
May. 30 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
May. 14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.14% | 53.2M | |
+40.73% | 739B | |
+32.26% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.87% | 240B | |
+9.57% | 210B | |
-5.48% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2025